Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLYS | Common Stock | Conversion of derivative security | +1.94M | 1.94M | Feb 14, 2023 | Direct | F1 | |||
transaction | MLYS | Common Stock | Conversion of derivative security | +964K | +49.67% | 2.91M | Feb 14, 2023 | Direct | F2 | ||
transaction | MLYS | Common Stock | Purchase | $5M | +313K | +10.76% | $16.00 | 3.22M | Feb 14, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLYS | Series A Preferred Stock | Conversion of derivative security | $0 | -21M | -100% | $0.00* | 0 | Feb 14, 2023 | Common Stock | 1.94M | Direct | F1 | |
transaction | MLYS | Series B Preferred Stock | Conversion of derivative security | $0 | -10.4M | -100% | $0.00* | 0 | Feb 14, 2023 | Common Stock | 964K | Direct | F2 |
HBM Healthcare Investments (Cayman) Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Upon the closing of the Issuer's initial public offering ("IPO"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date. |
F2 | Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date. |